Discounting in Cost-Utility Analysis of Healthcare Interventions Brian J. Cohen Current Opinion 22 September 2012 Pages: 75 - 87
European Healthcare Policies for Controlling Drug Expenditure Silvia M. EssSebastian SchneeweissThomas D. Szucs Review Article 22 September 2012 Pages: 89 - 103
Cost of Illness of Atopic Dermatitis in Children Andrew S. Kemp Review Article 22 September 2012 Pages: 105 - 113
Cost Analysis of Ropinirole versus Levodopa in the Treatment of Parkinson’s Disease Michael IskedjianThomas R. Einarson Original Research Article 22 September 2012 Pages: 115 - 127
Economic Implications of the Use of Basiliximab in Addition to Triple Immunosuppressive Therapy in Renal Allograft Recipients Stephen J. WaltersMalcolm WhitfieldJames B. Chilcott Original Research Article 22 September 2012 Pages: 129 - 138
Cost Effectiveness and Cost Utility of Acetylcysteine versus Dimethyl Sulfoxide for Reflex Sympathetic Dystrophy Hiske E. M. van DietenRoberto S. G. M. PerezMaarten Boers Original Research Article 22 September 2012 Pages: 139 - 148